Phillip Jobling Selected Research

Phillip Jobling Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 05/2015
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 12/2014
3	Pain (Aches) 11/2019 - 01/2014
3	Ganglion Cysts (Ganglion) 07/2005 - 11/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2020 - 01/2018
2	Cancer Pain 01/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
2	Adenocarcinoma 01/2020 - 01/2018
2	Schizophrenia (Dementia Praecox) 12/2019 - 01/2018
2	Carcinogenesis 12/2017 - 05/2015
1	Esophageal Squamous Cell Carcinoma 06/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Infections 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Small Cell Carcinoma 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2017
1	Contracture 10/2017
1	Breast Neoplasms (Breast Cancer) 10/2015
1	Pelvic Pain 01/2014
1	Substance-Related Disorders (Drug Abuse) 08/2012
1	Necrosis 11/2002

Drug/Important Bio-Agent (IBA)

9	Nerve Growth Factor (NGF)IBA 01/2023 - 12/2014
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2021 - 01/2018
3	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 06/2021 - 01/2018
3	sortilinIBA 07/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 07/2020 - 04/2003
3	Blocking AntibodiesIBA 01/2020 - 12/2014
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 05/2015
3	Nerve Growth Factors (Neurotrophins)IBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 12/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 05/2015
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020 - 01/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 01/2018
2	CytokinesIBA 01/2018 - 11/2002
1	AntibodiesIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	X-Box Binding Protein 1IBA 01/2022
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 07/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	ProstaglandinsIBA 01/2020
1	AF38469IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2020
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 12/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2019
1	Poly I-CIBA 12/2019
1	Analgesics (Analgesic Drugs)IBA 11/2019
1	LigandsIBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2015
1	CatecholaminesIBA 05/2015
1	Cocaine (Cocaine HCl)IBA 08/2012
1	OrexinsIBA 08/2012
1	SR 142801 (osanetant)IBA 07/2005
1	SR 140333IBA 07/2005
1	Interleukin-1 Type I ReceptorsIBA 11/2002
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2002
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2002
1	Interleukin-6 (Interleukin 6)IBA 11/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2014
3	Denervation 01/2020 - 01/2017
1	Investigational Therapies (Experimental Therapy) 01/2014